Key result
In over 4500 patients, computationally generated cardiac biomarkers were strongly associated with cardiovascular death over 2 years post-ACS, improving risk discrimination over existing clinical scores.
Why the study?
Do computationally generated cardiac biomarkers (MV, SM, HRM) improve risk stratification for cardiovascular death in patients after acute coronary syndrome compared to existing metrics?
Observational (n=4,500)
Blinded
Do computationally generated cardiac biomarkers (MV, SM, HRM) improve risk stratification for cardiovascular death in patients after acute coronary syndrome compared to existing metrics?
Computationally generated cardiac biomarkers from continuous ECG data significantly improve risk stratification for cardiovascular death after acute coronary syndrome beyond traditional clinical and echocardiographic metrics.
No takes yet. Share an insight, caveat, or question.
May support refined post-ACS risk stratification; leaves open prospective validation before clinical adoption.
Syed et al. (2011) conducted an observational in Acute coronary syndrome (n=4,500). Computationally generated cardiac biomarkers (morphologic variability, symbolic mismatch, and heart rate motifs) vs. Existing clinical risk scores, electrocardiographic metrics, and echocardiography was evaluated on Cardiovascular death. In over 4500 patients, computationally generated cardiac biomarkers were strongly associated with cardiovascular death over 2 years post-ACS, improving risk discrimination over existing clinical scores.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: